Objective determination of acoustic prescriptions
Presented herein are techniques that make use of objective measurements obtained in response to acoustic stimulation signals. More specifically, at least one measure of outer hair cell function and at least one measure of auditory nerve function are obtained from a tonotopic region of an inner ear of a recipient of a hearing prosthesis. The at least one measure of auditory nerve function and the least one measure of outer hair cell function are then analyzed relative to one another.
1. A method, comprising:
delivering one or more sets of acoustic stimulation signals to an inner ear of a recipient of a medical device;
obtaining, in response to the one or more sets of acoustic stimulation signals, at least one measure of outer hair cell function from a tonotopic region of the inner ear of the recipient;
determining whether the at least one measure of outer hair cell function differs from an expected measure of outer hair cell function for the tonotopic region of the inner ear to determine whether the at least one measure of outer hair cell function is expected;
obtaining, in response to the one or more sets of acoustic stimulation signals, at least one measure of auditory nerve function from the tonotopic region of the inner ear of the recipient;
determining whether the at least one measure of auditory nerve function differs from an expected measure of auditory nerve function for the tonotopic region of the inner ear to determine whether the at least one measure of auditory nerve function is expected;
determining the inner ear has a physiological abnormality based on one of the at least one measure of auditory nerve function or the at least one measure of outer hair cell function is expected and the other of the at least one measure of auditory nerve function or the at least one measure of outer hair cell function is unexpected; and
operating the medical device based on determining the inner ear has the physiological abnormality.
2. The method of claim 1 , further comprising:
generating an acoustic prescription for the recipient in response to determining the inner ear has the physiological abnormality, wherein operating the medical device based on determining the inner ear has the physiological abnormality comprises operating the medical device in accordance with the acoustic prescription.
3. The method of claim 1 , wherein the at least one measure of outer hair cell function comprises a cochlear microphonic evoked at the tonotopic region of the inner ear.
4. The method of claim 1 , further comprising:
obtaining, in response to the one or more sets of acoustic stimulation signals, a cochlear summating potential from the tonotopic region of the inner ear of the recipient.
5. The method of claim 1 , wherein the at least one measure of auditory nerve function comprises an auditory nerve neurophonic evoked at the tonotopic region of the inner ear.
6. The method of claim 1 , wherein delivering the one or more sets of acoustic stimulation signals to the inner ear of the recipient of the medical device comprises:
delivering the one or more sets of acoustic stimulation signals at a selected and substantially constant frequency.
7. The method of claim 1 , wherein delivering the one or more sets of acoustic stimulation signals to the inner ear of the recipient of the medical device comprises:
incrementally adjusting an amplitude of the one or more sets of acoustic stimulation signals.
8. A system, comprising:
a receiver configured to deliver acoustic stimulus;
at least one recording electrode configured to measure physiological potentials of an inner ear of a patient in response to the acoustic stimulus; and
one or more processors configured to:
obtain at least one cochlear microphonic evoked at a tonotopic region of the inner ear of the patient;
obtain at least one auditory nerve neurophonic evoked at the tonotopic region of the inner ear of the patient;
determine whether the at least one cochlear microphonic differs from an expected cochlear microphonic for the tonotopic region of the inner ear of the patient;
determine whether the at least one auditory nerve neurophonic differs from an expected auditory nerve neurophonic for the tonotopic region of the inner ear of the patient; and
determine a treatment for the inner ear based on a comparison of any differences between the at least one cochlear microphonic and the expected cochlear microphonic with any differences between the at least one auditory nerve neurophonic and the expected auditory nerve neurophonic.
9. The system of claim 8 , wherein the one or more processors are configured to:
determine the treatment for the inner ear in response to there being a difference between the at least one cochlear microphonic and the expected cochlear microphonic and there being no difference between the at least one auditory nerve neurophonic and the expected auditory nerve neurophonic.
10. The system of claim 8 , wherein the one or more processors are configured to:
determine the treatment for the inner ear in response to there being no difference between the at least one cochlear microphonic and the expected cochlear microphonic and there being a difference between the at least one auditory nerve neurophonic and the expected auditory nerve neurophonic.
11. The system of claim 8 , comprising an amplifier configured to amplify the physiological potentials measured by the at least one recording electrode for obtaining the at least one cochlear microphonic and the at least one auditory nerve neurophonic at the one or more processors.
12. The system of claim 8 , wherein the treatment comprises at least one of an input/output for the inner ear or a gain function for the inner ear.
13. A method, comprising:
obtaining at least one cochlear microphonic evoked at a tonotopic region of an inner ear of a patient;
obtaining at least one auditory nerve neurophonic evoked at the tonotopic region of the inner ear of the patient;
comparing the at least one cochlear microphonic to an expected cochlear microphonic for the tonotopic region of the inner ear to provide a first comparison result;
comparing the at least one auditory nerve neurophonic to an expected auditory nerve neurophonic for the tonotopic region of the inner ear to provide a second comparison result;
comparing the first comparison result with the second comparison result; and
determining a treatment based on comparison between the first comparison result and the second comparison result.
14. The method of claim 13 , further comprising:
delivering one or more sets of acoustic stimulation signals to the inner ear of the patient,
wherein the at least one cochlear microphonic and the at least one auditory nerve neurophonic are obtained in response to the one or more sets of acoustic stimulation signals.
15. The method of claim 14 , wherein delivering the one or more sets of acoustic stimulation signals to the inner ear of the patient comprises:
delivering the one or more sets of acoustic stimulation signals at a selected and substantially constant frequency while incrementally adjusting an amplitude of the one or more sets of acoustic stimulation signals.
16. The method of claim 13 , wherein determining the treatment based on the comparison between the first comparison result and the second comparison result comprises:
generating an acoustic prescription in response to a difference between the first comparison result and the second comparison result.
17. The method of claim 16 , wherein the first comparison result comprises a difference between the at least one cochlear microphonic and the expected cochlear microphonic, and the second comparison result comprises a match between the at least one auditory nerve neurophonic and the expected auditory nerve neurophonic.
18. The method of claim 16 , wherein the first comparison result comprises a match between the at least one cochlear microphonic and the expected cochlear microphonic, and the second comparison result comprises a difference between the at least one auditory nerve neurophonic and the expected auditory nerve neurophonic.
19. The method of claim 13 , wherein the treatment comprises electrical stimulation at frequencies below a frequency corresponding to the tonotopic region.
20. The method of claim 19 , wherein the treatment comprises acoustic stimulation at frequencies above the frequency corresponding to the tonotopic region.